News •
Knowledge about the genetic defects that lead to cancer suggests that cancer can be treated by fixing those altered genes. One strategy is to replace a defective gene with its normal counterpart, using methods of recombinant DNA technology. Methods to insert genes into tumour cells and to introduce genes that alter the tumour microenvironment or modify oncolytic viruses to make them more effective are of particular interest.
Strategies for cancer prevention
Specific agents are known to cause certain types of cancer, and cancer death rates might therefore be reduced through avoidance of those factors. One such preventative action is to avoid smoking tobacco. In the case of certain viruses that are linked to cancer—for example, hepatitis B virus, which is linked to liver cancer—vaccination campaigns may reduce cancer incidence. Certain modifications of diet—such as eating more fruits, vegetables, and legumes (e.g., peas and beans) and less red meat, processed meat, and saturated fats—can increase the odds of avoiding cancer. International epidemiological and laboratory studies provide strong evidence that a high intake of dietary fat is associated with an increased incidence of breast, colon, rectal, and prostate cancer.
Chemoprevention
Chemoprevention is the use of chemical compounds to intervene in the early precancerous stages of carcinogenesis (the development of cancer) and thereby reverse tumour formation. Many chemopreventive agents, both natural and synthetic, have been identified. Some of the most-promising compounds are found in vegetables and fruits. For example, dithiothiones are potential chemopreventive agents that naturally occur in broccoli and cauliflower. A number of anticancer drugs under study also show promise in preventing cancer. Those include antiestrogen drugs such as tamoxifen, which has been shown to reduce the incidence of breast cancer.
Individuals with precancerous lesions and those with a previous cancer who are at risk for a second tumour are most often included in chemoprevention research trials.
Screening and early detection
It is possible to screen asymptomatic individuals for various types of cancer, such as breast, cervical, prostate, colorectal, and skin cancers. In those instances tests can detect a precancerous condition or a tumour in an early stage so that it can be removed. For example, self-examination of the breasts and yearly mammograms contribute significantly to the early detection of tumours and the success of therapy. Self-exams are also useful in detecting early stages of testicular cancer. In other cases, however, such as when a detectable preclinical phase of a cancer is not known or there is no effective treatment for the cancer, screening programs may not be beneficial. Furthermore, a number of lesions identified during screening and subjected to biopsy or additional investigation never progress to cancer. But because there often are no reliable means to differentiate between lesions that will rapidly progress from those that will remain latent, many individuals undergo unnecessary treatment, which could expose them to complications. These concerns are particularly valid for prostate cancer and for early breast cancer. It is hoped that the molecular characterization of the earliest lesions that have the potential to progress may provide an objective means to predict the biological course of these lesions.
The discovery and development of improved methods for the screening and early detection of cancer form a major area of cancer research. Improvements in cancer screening centre largely on refinements in the use of traditional tumour biomarkers, the discovery of new biomarkers, and advances in imaging techniques. Novel markers for cancer screening and detection, including circulating tumour DNA and circulating tumour cells, are of particular interest. Advances in early cancer detection methods include the development of noninvasive tests, such as serum, blood, and breath tests. In the case of breath tests, subtle differences in the composition of volatile organic compounds in an individual’s breath can potentially be detected using a simple device.